Teva's CFO indicated that Teva is a minor player in those two countries for a reason: there are many local generic companies there that produce cheap low quality generics. Teva is waiting for regulatory changes to make it adequate for them. Teva has almost no presence in Brazil but they intend to penetrate to this market since regulatory environment is changing there.
Market Data 
Markets 
AI
